Patents by Inventor Judith E. Caterini

Judith E. Caterini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030228304
    Abstract: Antibody molecules specific for surface structures of antigen presenting cells that have been modified to include an antigen moiety at a specific site therein to produce novel conjugate antibody molecules are disclosed. These conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody, and expression in mammalian cells to produce the conjugate antibody. The conjugate antibody retained specificity for antigen presenting cells and contained the antigen moiety. The conjugate antibody molecules deliver the antigen to antigen presenting cells to produce an enhanced immune response to a host immunized therewith. The conjugate antibody molecules and nucleic acid molecules encoding them are useful as antigens and as immunogene in diagnostic and prophylactic applications.
    Type: Application
    Filed: May 5, 2003
    Publication date: December 11, 2003
    Inventors: Naveen N. Anand, Brian H. Barber, George A. Cates, Judith E. Caterini, Michel H. Klein
  • Publication number: 20020025315
    Abstract: Antibody molecules specific for surface structures of antigen presenting cells that have been modified to include an antigen moiety at a specific site therein to produce novel conjugate antibody molecules are disclosed. These conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody, and expression in mammalian cells to produce the conjugate antibody. The conjugate antibody retained specificity for antigen presenting cells and contained the antigen moiety. The conjugate antibody molecules deliver the antigen to antigen presenting cells to produce an enhanced immune response to a host immunized therewith.
    Type: Application
    Filed: January 14, 1998
    Publication date: February 28, 2002
    Inventors: NAVEEN N. ANAND, BRIAN H. BARBER, GEORGE A. CATES, JUDITH E. CATERINI, MICHEL H. KLEIN
  • Patent number: 6328962
    Abstract: Antibody molecules specific for surface structures of antigen presenting cells that have been modified to include an antigen moiety at a specific site therein to produce novel conjugate antibody molecules are disclosed. These conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody, and expression in mammalian cells to produce the conjugate antibody. The conjugate antibody retained specificity for antigen presenting cells and contained the antigen moiety. The conjugate antibody molecules deliver the antigen to antigen presenting cells to produce an enhanced immune response to a host immunized therewith. The conjugate antibody molecules and nucleic acid molecules encoding them are useful as antigens and as immunogens in diagnostic and prophylactic applications.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: December 11, 2001
    Assignee: Aventis Pasteur Limited
    Inventors: Naveen N. Anand, Brian H. Barber, George A. Cates, Judith E. Caterini, Michel H. Klein
  • Patent number: 6291208
    Abstract: Antibody molecules specific for surface structures of antigen presenting cells that have been modified to include an antigen moiety at a specific site therein to produce novel conjugate antibody molecules are disclosed. These conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody, and expression in mammalian cells to produce the conjugate antibody. The conjugate antibody retained specificity for antigen presenting cells and contained the antigen moiety. The conjugate antibody molecules deliver the antigen to antigen presenting cells to produce an enhanced immune response to a host immunized therewith. The conjugate antibody molecules and nucleic acid molecules encoding them are useful as antigens and as immunogens in diagnostic and prophylactic applications.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: September 18, 2001
    Assignee: Aventis Pasteur Limited
    Inventors: Naveen N. Anand, Brian H. Barber, George C. Cates, Judith E. Caterini, Michel H. Klein
  • Publication number: 20010014327
    Abstract: Antibody molecules specific for surface structures of antigen presenting cells that have been modified to include an antigen moiety at a specific site therein to produce novel conjugate antibody molecules are disclosed. These conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody, and expression in mammalian cells to produce the conjugate antibody. The conjugate antibody retained specificity for antigen presenting cells and contained the antigen moiety. The conjugate antibody molecules deliver the antigen to antigen presenting cells to produce an enhanced immune response to a host immunized therewith. The conjugate antibody molecules and nucleic acid molecules encoding them are useful as antigens and as immunogens in diagnostic and prophylactic applications.
    Type: Application
    Filed: April 7, 1998
    Publication date: August 16, 2001
    Inventors: NAVEEN N ANAND, BRIAN H. BARBER, GEORGE C. CATES, JUDITH E. CATERINI, MICHEL H. KLEIN